Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Liina Hannula"'
Autor:
Liina Hannula, Suvi Kuivanen, Jonathan Lasham, Ravi Kant, Lauri Kareinen, Mariia Bogacheva, Tomas Strandin, Tarja Sironen, Jussi Hepojoki, Vivek Sharma, Petri Saviranta, Anja Kipar, Olli Vapalahti, Juha T. Huiskonen, Ilona Rissanen
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 4 (2024)
ABSTRACTIn response to the ongoing COVID-19 pandemic, the quest for coronavirus inhibitors has inspired research on a variety of small proteins beyond conventional antibodies, including robust single-domain antibody fragments, i.e., “nanobodies.”
Externí odkaz:
https://doaj.org/article/cecbf8f257de4f2482e0413c26276bab
Autor:
Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, Ravi Kant, Petja Salminen, Riku Fagerlund, Sanna Mäki, Anu Haveri, Tomas Strandin, Lauri Kareinen, Jussi Hepojoki, Suvi Kuivanen, Lev Levanov, Arja Pasternack, Rauno A. Naves, Olli Ritvos, Pamela Österlund, Tarja Sironen, Olli Vapalahti, Anja Kipar, Juha T. Huiskonen, Ilona Rissanen, Kalle Saksela
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Here the authors describe a small antibody-like protein that can prevent infection by diverse SARS-CoV-2 variants in cell culture and in mice that were intranasally treated with this inhibitor before or shortly after being exposed to the virus.
Externí odkaz:
https://doaj.org/article/326654b56d2c4bd89b56074f0855fd2f
Autor:
Liina Hannula, Suvi Kuivanen, Jonathan Lasham, Ravi Kant, Lauri Kareinen, Mariia Bogacheva, Tomas Strandin, Tarja Sironen, Vivek Sharma, Petri Saviranta, Anja Kipar, Olli Vapalahti, Juha T. Huiskonen, Ilona Rissanen
Publikováno v:
BioRxiv
bioRxiv
bioRxiv
In response to the ongoing SARS-CoV-2 pandemic, the quest for coronavirus inhibitors has inspired research on a variety of small proteins beyond conventional antibodies, including robust single-domain antibody fragments, ‘nanobodies’. Here, we ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937dd6201d28d993d4bb79234a14dec2
Autor:
Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, Petja Salminen, Ravi Kant, Riku Fagerlund, Anu Haveri, Tomas Strandin, Lauri Kareinen, Jussi Hepojoki, Lev Levanov, Arja Pasternack, Rauno A. Naves, Olli Ritvos, Pamela Österlund, Tarja Sironen, Olli Vapalahti, Anja Kipar, Juha T. Huiskonen, Ilona Rissanen, Kalle Saksela
The emergence of the SARS-CoV-2 Omicron variant capable of escaping neutralizing antibodies emphasizes the need for prophylactic strategies to complement vaccination in fighting the COVID-19 pandemic. Nasal epithelium is rich in the ACE2 receptor and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24e74811f49ed4a374d136c5d4502172
https://doi.org/10.21203/rs.3.rs-1196079/v1
https://doi.org/10.21203/rs.3.rs-1196079/v1
Autor:
Emily Sessa, Weston Testo, Peris Kamau, Henry Väre, Liina Hannula, Jouko Rikkinen, Aino Kaisa Juslen
Publikováno v:
University of Helsinki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::17e16a7e0da6ce1f3781b65ace2ef12c
https://researchportal.helsinki.fi/en/publications/cf7faa54-1b6c-4317-b0e6-4632cad11ce7
https://researchportal.helsinki.fi/en/publications/cf7faa54-1b6c-4317-b0e6-4632cad11ce7
Autor:
Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, Ravi Kant, Petja Salminen, Riku Fagerlund, Sanna Mäki, Anu Haveri, Tomas Strandin, Lauri Kareinen, Jussi Hepojoki, Suvi Kuivanen, Lev Levanov, Arja Pasternack, Rauno A. Naves, Olli Ritvos, Pamela Österlund, Tarja Sironen, Olli Vapalahti, Anja Kipar, Juha T. Huiskonen, Ilona Rissanen, Kalle Saksela
Publikováno v:
bioRxiv
BioRxiv
BioRxiv
SUMMARYThe recent emergence of novel SARS-CoV-2 variants capable of efficiently escaping neutralizing antibodies emphasizes the need for prophylactic strategies to complement vaccination in fighting the COVID-19 pandemic. Nasal epithelium is rich in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd85234534486633e766b228fd1994d